Cargando…

Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness

BACKGROUND: People with severe mental illness (SMI) show significantly shorter life expectancy, mostly due to more prevalent cardiovascular disease. Although age is a prominent contributor to contemporary risk assessment and SMI usually affects younger people, these assessments still do not reveal t...

Descripción completa

Detalles Bibliográficos
Autores principales: Emmerink, Daniëlle, Bakker, Sybiel, Van Bemmel, Thomas, Noorthoorn, Eric O., Naarding, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066984/
https://www.ncbi.nlm.nih.gov/pubmed/30083385
http://dx.doi.org/10.1192/bjo.2018.34
_version_ 1783343070067032064
author Emmerink, Daniëlle
Bakker, Sybiel
Van Bemmel, Thomas
Noorthoorn, Eric O.
Naarding, Paul
author_facet Emmerink, Daniëlle
Bakker, Sybiel
Van Bemmel, Thomas
Noorthoorn, Eric O.
Naarding, Paul
author_sort Emmerink, Daniëlle
collection PubMed
description BACKGROUND: People with severe mental illness (SMI) show significantly shorter life expectancy, mostly due to more prevalent cardiovascular disease. Although age is a prominent contributor to contemporary risk assessment and SMI usually affects younger people, these assessments still do not reveal the actual risk. By assessing advanced glycation end products (AGEs), cardiovascular risk can be assessed independent of age. AIMS: To establish whether detection of AGEs with the AGE-reader will give a more accurate cardiovascular risk assessment in people with SMI. METHOD: We compared assessment with the AGE-reader with that of the Systematic Coronary Risk Evaluation (SCORE) table in a group of 120 patients with SMI. RESULTS: The AGE-reader showed an increased cardiovascular risk more often than the SCORE table, especially in the youngest group. CONCLUSIONS: Because of its ease of use and substantiation by studies done on other chronic diseases, we advocate use of the AGE-reader in daily care for patients with SMI to detect cardiovascular risk as early as possible. However, the findings of the current study should be evaluated with caution and should be seen as preliminary findings that require confirmation by a prospective longitudinal cohort study with a substantial follow-up observation period. DECLARATION OF INTEREST: None.
format Online
Article
Text
id pubmed-6066984
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-60669842018-08-06 Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness Emmerink, Daniëlle Bakker, Sybiel Van Bemmel, Thomas Noorthoorn, Eric O. Naarding, Paul BJPsych Open Papers BACKGROUND: People with severe mental illness (SMI) show significantly shorter life expectancy, mostly due to more prevalent cardiovascular disease. Although age is a prominent contributor to contemporary risk assessment and SMI usually affects younger people, these assessments still do not reveal the actual risk. By assessing advanced glycation end products (AGEs), cardiovascular risk can be assessed independent of age. AIMS: To establish whether detection of AGEs with the AGE-reader will give a more accurate cardiovascular risk assessment in people with SMI. METHOD: We compared assessment with the AGE-reader with that of the Systematic Coronary Risk Evaluation (SCORE) table in a group of 120 patients with SMI. RESULTS: The AGE-reader showed an increased cardiovascular risk more often than the SCORE table, especially in the youngest group. CONCLUSIONS: Because of its ease of use and substantiation by studies done on other chronic diseases, we advocate use of the AGE-reader in daily care for patients with SMI to detect cardiovascular risk as early as possible. However, the findings of the current study should be evaluated with caution and should be seen as preliminary findings that require confirmation by a prospective longitudinal cohort study with a substantial follow-up observation period. DECLARATION OF INTEREST: None. Cambridge University Press 2018-07-25 /pmc/articles/PMC6066984/ /pubmed/30083385 http://dx.doi.org/10.1192/bjo.2018.34 Text en © The Royal College of Psychiatrists 2018 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Papers
Emmerink, Daniëlle
Bakker, Sybiel
Van Bemmel, Thomas
Noorthoorn, Eric O.
Naarding, Paul
Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
title Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
title_full Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
title_fullStr Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
title_full_unstemmed Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
title_short Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
title_sort skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
topic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066984/
https://www.ncbi.nlm.nih.gov/pubmed/30083385
http://dx.doi.org/10.1192/bjo.2018.34
work_keys_str_mv AT emmerinkdanielle skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness
AT bakkersybiel skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness
AT vanbemmelthomas skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness
AT noorthoornerico skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness
AT naardingpaul skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness